Table 1.
Characteristics of Candidates for Left Ventricular Assist Device Implantation
| Variablea | All (n = 82) |
Group Significant-Post-MR (n = 13) |
Group None/Mild-Post-MR (n = 64) |
Group MVr (n = 5) |
p-value |
|---|---|---|---|---|---|
| Age, y | 56.6 ± 13.7 | 50.2 ± 15.0 | 57.6 ± 13.4 | 59.8 ± 12.0 | 0.204 |
| Male gender | 59 (72.0) | 9 (69.2) | 47 (73.4) | 3 (60.0) | 0.926 |
| Blood pressure, mm Hg | |||||
| Pre-LVAD | 76 ± 11 | 79 ± 8 | 75 ± 11 | 74 ± 11 | 0.365 |
| Post-LVAD | 82 ± 11 | 79 ± 10 | 83 ± 11 | 82 ± 10 | 0.474 |
| Ischemic heart disease | 60 (73.2) | 12 (92.3) | 45 (70.3) | 3 (60.0) | 0.209 |
| Diabetes | 26 (31.7) | 1 (7.7) | 23 (35.9) | 2 (40.0) | 0.126 |
| Hypertension | 42 (51.2) | 6 (46.2) | 34 (53.1) | 2 (40.0) | 0.787 |
| Hyperlipidemia | 28 (34.1) | 4 (30.8) | 22 (34.4) | 2 (40.0) | 0.931 |
| Cerebrovascular disease | 16 (19.5) | 1 (7.7) | 14 (21.9) | 1 (20.0) | 0.5 |
| WBC, × 103 / μl | 8.51 ± 3.36 | 8.32 ± 2.64 | 8.77 ± 3.50 | 6.18 ± 2.68 | 0.443 |
| Platelets, × 103 / μl | 19.1 ± 7.3 | 20.9 ± 7.1 | 18.7 ± 7.1 | 19.7 ± 10.0 | 0.471 |
| BUN, mg/dl | 33.6 ± 16.8 | 27.2 ± 11.3 | 35.4 ± 17.8 | 28.2 ± 11.3 | 0.175 |
| Creatinine, mg/dl | 1.5 ± 0.5 | 1.5 ± 0.5 | 1.5 ± 0.5 | 1.3 ± 0.4 | 0.7 |
| AST, IU/liters | 49.2 ± 74.5 | 51.1 ± 69.0 | 50.7 ± 79.2 | 28.2 ± 8.0 | 0.815 |
| ALT, IU/liters | 88.8 ± 250.3 | 54.9 ± 105.8 | 101.4 ± 280.4 | 27.2 ± 9.2 | 0.716 |
| Total bilirubin, mg/dl | 1.6 ± 0.9 | 1.9 ± 1.2 | 1.6 ± 0.9 | 1.0 ± 0.5 | 0.13 |
| Albumin, g/dl | 3.5 ± 0.5 | 3.5 ± 0.5 | 3.6 ± 0.5 | 3.7 ± 0.6 | 0.908 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; LVAD, left ventricular assist device; MR, mitral regurgitation; MVr, mitral valve repair; WBC, white blood cell.
a
Categoric variables are shown as number (%) and continuous variables as mean ± standard deviation.